Brief report: RET genetic screening in patients with medullary thyroid cancer and their relatives: Experience with 807 individuals at one center

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 12, 2007, Pages 4725-4729

  Elisei, Rossella ^a   Romei, Cristina ^a   Cosci, Barbara ^a   Agate, Laura ^a   Bottici, Valeria ^a   Molinaro, Eleonora ^a   Sculli, Mariangela ^a   Miccoli, Paolo ^a   Basolo, Fulvio ^a   Grasso, Lucia ^a   Pacini, Furio ^b   Pinchera, Aldo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN RET;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CENTER; CANCER CLASSIFICATION; CANCER INCIDENCE; CHILD; CODON; DNA DETERMINATION; DNA EXTRACTION; EXON; FAMILIAL CANCER; FEMALE; GENE SEQUENCE; GENETIC SCREENING; GERM LINE; HERITABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; GENETICS; GENOTYPE; MEDULLARY CARCINOMA; MIDDLE AGED; MUTATION; PHENOTYPE; PHYSIOLOGY; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MEDULLARY; CODON; EXONS; FEMALE; GENETIC SCREENING; GENOTYPE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS;

EID: 36849056630     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1005     Document Type: Article

References (20)

1. Hazard JB, Hawk WA, Crile Jr G 1959 Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. J Clin Endocrinol Metab 19:152-161
2. Melvin KE, Tashjian Jr AH 1968 The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid. Proc Natl Acad Sci USA 59:1216-1222
3. Pinchera A, Elisei R 2006 Medullary thyroid cancer: diagnosis and management. In: Mazzaferri EL, Ujjal K, Mallick UK, Kendall-Taylor P, eds. Practical management of thyroid cancer. London: Springer-Verlag; 255-279
4. Keiser HR, Beaven MA, Doppman J, Wells Jr S, Buja LM 1973 Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conference. Ann Intern Med 78:561-579
5. Cunliffe WJ, Hudgson P, Fulthorpe JJ, Black MM, Hall R, Johnston ID, Shuster S 1970 A calcitonin-secreting medullary thyroid carcinoma associated with mucosal neuromas, marfanoid features, myopathy and pigmentation. Am J Med 48:120-126
6. Farndon JR, Leight GS, Dilley WG, Baylin SB, Smallridge RC, Harrison TS, Wells Jr SA 1986 Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg 73:278-281
7. Mathew CG, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI, Fong SL, Bridges CD, Haak H, Kruseman AC, Schifter S, Hansen HH, Telenius H, Telenius-Berg M, Ponder BA 1987 A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328:527-528
8. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder BAJ 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460
9. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells Jr SA 1993 Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851-856
10. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A, Ponder BAJ 1994 Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet [Erratum (1994) 3:686] 3:237-241
11. Niccoli-Sire P, Murat A, Rohmer V, Franc S, Chabrier G, Baldet L, Maes B, Savagner F, Giraud S, Bezieau S, Kottler ML, Morange S, Conte-Devolx B 2001 Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients. J Clin Endocrinol Metab 86:3746-3753
12. Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO 2004 A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. J Clin Endocrinol Metab 89:3521-3526
13. Elisei R, Cosci B, Romei C, Bottici V, Sculli M, Lari R, Barale R, Pacini F, Pinchera A 2004 RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. J Clin Endocrinol Metab 89:3579-3584
14. Elisei R, Cosci B, Romei C, Agate L, Piampiani P, Miccoli P, Berti P, Basolo F, Ugolini C, Ciampi R, Nikiforov Y, Pinchera A 2004 Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition. J Clin Endocrinol Metab 89:5823-5827
15. Bugalho MJ, Domingues R, Santos JR, Catarino AL, Sobrinho L 2007 Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre. Surgery 141:90-95
16. Wiench M, Wygoda Z, Gubala E, Wloch J, Lisowska K, Krassowski J, Scieglinska D, Fiszer-Kierzkowska A, Lange D, Kula D, Zeman M, Roskosz J, Kukulska A, Krawczyk Z, Jarzab B 2001 Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients. J Clin Oncol 19:1374-1380
17. Vierhapper H, Bieglmayer C, Heinze G, Baumgartner-Parzer S 2004 Frequency of RET proto-oncogene mutations in patients with normal and with moderately elevated pentagastrin-stimulated serum concentrations of calcitonin. Thyroid 14:580-583
18. Gharib H, McConahey WM, Tiegs RD, Bergstralh EJ, Goellner JR, Grant CS, van Heerden JA, Sizemore GW, Hay ID 1992 Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 67:934-940
19. Wells Jr SA, Franz C 2000 Medullary carcinoma of the thyroid gland. World J Surg 24:952-956
20. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjold M, Komminoth P, Hendy GN, Mulligan LM 1996 The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575-1579